CGP52411
CGP52411 is an orally bioavailable, ATP-competitive EGFR inhibitor (IC50: 0.3 μM) with research applications in Alzheimer's disease. It demonstrates neuroprotective effects by blocking toxic calcium influx and potently inhibiting and reversing Aβ42 fibril aggregation in vitro.
Product Specifications
CAS Number
145915-58-8
Product Name Alternative
β Amyloid, βAmyloid, bAmyloid, Amyloid-β, b Amyloid, CGP 52411, CGP52411, CGP-52411, BetaAmyloid, Beta Amyloid, DAPH, EGFR
Field of Research
Cardiovascular Research, Neuroscience, Signal Transduction
Purity
99.56% (May vary between batches)
Solubility
DMSO:90 mg/mL (273.27 mM)
Smiles
O=C1NC (=O) c2cc (Nc3ccccc3) c (Nc3ccccc3) cc12
Molecular Formula
C20H15N3O2
Molecular Weight
329.35
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
bs-8184R-PE-Cy5.5 100 µL
AVSD2 Polyclonal Antibody, PE-Cy5.5 Conjugated
Sign In for Pricing
View Details 
241291-01 100 mg
(Piperidin-4-yloxy) acetic acid methyl ester hydrochloride ≥97% (HPLC)
Sign In for Pricing
View Details 241291-02 250 mg
(Piperidin-4-yloxy) acetic acid methyl ester hydrochloride ≥97% (HPLC)
Sign In for Pricing
View Details